Prefillable Biological Drug Delivery Systems


Specialty prefilled injection devices – a group that includes pen injectors and autoinjectors – are creating new opportunities for drug developers and marketers. These devices provide the ability to create product differentiation in the age of direct-to-consumer marketing.



Because biological drugs most often target chronic conditions, dosing strategies and treatment protocols must be developed for long-term use, often for self-administration by patients who may have limitations directly related to their condition. The shift in as-supplied packaging from single and multi-use vials to prefilled injection devices will accelerate over the next five years as drug developers move to empower an increasing number of chronically ill patients. The powerful physiological effects of antibodies, hormones and other biological drugs also increase the need for safety and compliance.